Interact to see
Advertisement
Advertisement
CCGEX vs RNPCX
CCGEX vs RNPCX Comparison
Open Charts CCGEX vs RNPCX
Calamos Global Equity C
Price$14.81
Change-$0.37 (-2.44%)
VolumeN/A
Net Assets159.9M
American Funds New Perspective R3
Price$71.42
Change-$1.20 (-1.65%)
VolumeN/A
Net Assets165.22B
CCGEX vs RNPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CCGEX vs. RNPCX commentary
Nov 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCGEX is a Buy and RNPCX is a Hold.
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 165B vs. CCGEX (160M). RNPCX pays higher dividends than CCGEX: RNPCX (0.21) vs CCGEX (0.00). CCGEX was incepted earlier than RNPCX: CCGEX (19 years) vs RNPCX (23 years). CCGEX (2.17) is less costly to investors than RNPCX (1.06). CCGEX is a more actively managed with annual turnover of: 78.00 vs. RNPCX (24.00). RNPCX has a lower initial minimum investment than CCGEX: RNPCX (250) vs CCGEX (2500). RNPCX annual gain was more profitable for investors over the last year : 12.56 vs. CCGEX (2.14). RNPCX return over 5 years is better than : 29.62 vs. CCGEX (13.31).
| CCGEX | RNPCX | CCGEX / RNPCX | |
| Total Expense Ratio | 2.15 | 1.06 | 203% |
| Annual Report Gross Expense Ratio | 2.17 | 1.06 | 205% |
| Fund Existence | 19 years | 23 years | - |
| Gain YTD | 16.157 | 18.895 | 86% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 160M | 165B | 0% |
| Annual Yield % from dividends | 0.00 | 0.21 | - |
| Returns for 1 year | 2.14 | 12.56 | 17% |
| Returns for 3 years | 53.63 | 48.35 | 111% |
| Returns for 5 years | 13.31 | 29.62 | 45% |
| Returns for 10 years | 20.80 | 92.30 | 23% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTIX | 41.04 | N/A | N/A |
| Fidelity Advisor Biotechnology I | |||
| DGOYX | 46.97 | -0.65 | -1.36% |
| Davis Opportunity Y | |||
| GEMQX | 14.74 | -0.22 | -1.47% |
| Goldman Sachs Emerging Mkts Eq ex. Chn R | |||
| TVOIX | 40.72 | -0.70 | -1.69% |
| Touchstone Small Cap Value Institutional | |||
| TWSIX | 145.37 | -3.23 | -2.17% |
| American Century Select I | |||